Company Directory / information technology & services
PrivateFor profitinformation technology & servicesSingapore, Singapore
Mesh Bio
Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.
- Founded
- 2018 8 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $5.3M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
8 years old.
Reach
Website ranked #6,034,419 in the world for traffic, about 1k visits a month.
What it does
AnalyticsArtificial Intelligence (AI)BiotechnologyHealth CareInformation TechnologyPredictive Analytics
Funding, as listed
$5.3M currency not stated
- Rounds2
- LatestSeries a, Oct 2023
- Investors7, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Mesh Bio, field by field. Contact details are held but never shown.
The company
- Name
- Mesh Bio
- Type
- For profit
- Status
- Private
- Founded
- 2018
- Founders
- Andrew Wu, Arsen Batagov, Melvin Heng
- Industry
- information technology & services
- Categories
- Analytics, Artificial Intelligence (AI), Biotechnology, Health Care, Information Technology, Predictive Analytics
Where
- City
- Singapore
- Country
- Singapore
- Markets
- Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #6,034,419
- Monthly web visits
- 1,152
Funding, as listed
- Total
- 5,300,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series a
- Latest round date
- Oct 2023
- Investors
- 7
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Mesh Bio may be growing as it has successfully completed a Series A funding round, which is a significant indicator of investor confidence and financial backing for future operations. The completion of this funding round typically provides a startup with the capital required to expand its team, develop new products, or enter new markets. Additionally, being featured in a Forbes article suggests that Mesh Bio is gaining recognition in the healthtech industry, which could contribute to its growth by attracting potential customers or additional investors.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
information technology & services in Singapore.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 17,167 companies in Singapore and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.